{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:05:06Z","timestamp":1793329506684,"version":"4.5.0"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T00:00:00Z","timestamp":1556496000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T00:00:00Z","timestamp":1556496000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["Z01 DE000649"],"award-info":[{"award-number":["Z01 DE000649"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s00223-019-00550-z","type":"journal-article","created":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T02:05:17Z","timestamp":1556503517000},"page":"517-529","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":83,"title":["Fibrous Dysplasia of Bone and McCune\u2013Albright Syndrome: A Bench to Bedside Review"],"prefix":"10.1007","volume":"104","author":[{"given":"Iris","family":"Hartley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Zhadina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micheal T.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2987-3887","authenticated-orcid":false,"given":"Alison M.","family":"Boyce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,29]]},"reference":[{"issue":"4","key":"550_CR1","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1007\/s12105-014-0590-0","volume":"8","author":"SK El-Mofty","year":"2014","unstructured":"El-Mofty SK (2014) Fibro-osseous lesions of the craniofacial skeleton: an update. Head Neck Pathol 8(4):432\u2013444","journal-title":"Head Neck Pathol"},{"issue":"1","key":"550_CR2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/SCS.0000000000002830","volume":"28","author":"L Yang","year":"2017","unstructured":"Yang L et al (2017) Prevalence of different forms and involved bones of craniofacial fibrous dysplasia. J Craniofac Surg 28(1):21\u201325","journal-title":"J Craniofac Surg"},{"issue":"24","key":"550_CR3","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1056\/NEJM199112123252403","volume":"325","author":"LS Weinstein","year":"1991","unstructured":"Weinstein LS et al (1991) Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med 325(24):1688\u20131695","journal-title":"N Engl J Med"},{"issue":"16","key":"550_CR4","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1093\/hmg\/ddm139","volume":"16","author":"S Michienzi","year":"2007","unstructured":"Michienzi S et al (2007) GNAS transcripts in skeletal progenitors: evidence for random asymmetric allelic expression of Gs alpha. Hum Mol Genet 16(16):1921\u20131930","journal-title":"Hum Mol Genet"},{"issue":"1","key":"550_CR5","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41594-017-0011-7","volume":"25","author":"D Hilger","year":"2018","unstructured":"Hilger D, Masureel M, Kobilka BK (2018) Structure and dynamics of GPCR signaling complexes. Nat Struct Mol Biol 25(1):4\u201312","journal-title":"Nat Struct Mol Biol"},{"issue":"5","key":"550_CR6","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1210\/jc.2003-031225","volume":"89","author":"S Lumbroso","year":"2004","unstructured":"Lumbroso S et al (2004) Activating gsalpha mutations: analysis of 113 patients with signs of McCune-Albright syndrome\u2013a European Collaborative Study. J Clin Endocrinol Metab 89(5):2107\u20132113","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"550_CR7","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1359\/jbmr.2000.15.1.120","volume":"15","author":"P Bianco","year":"2000","unstructured":"Bianco P et al (2000) Mutations of the GNAS1 gene, stromal cell dysfunction, and osteomalacic changes in non-McCune-Albright fibrous dysplasia of bone. J Bone Miner Res 15(1):120\u2013128","journal-title":"J Bone Miner Res"},{"issue":"6","key":"550_CR8","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/j.1365-2559.2007.02676.x","volume":"50","author":"BD Idowu","year":"2007","unstructured":"Idowu BD et al (2007) A sensitive mutation-specific screening technique for GNAS1 mutations in cases of fibrous dysplasia: the first report of a codon 227 mutation in bone. Histopathology 50(6):691\u2013704","journal-title":"Histopathology"},{"issue":"26","key":"550_CR9","doi-asserted-by":"crossref","first-page":"15475","DOI":"10.1016\/S0021-9258(19)84854-8","volume":"264","author":"MP Graziano","year":"1989","unstructured":"Graziano MP, Gilman AG (1989) Synthesis in Escherichia coli of GTPase-deficient mutants of Gs alpha. J Biol Chem 264(26):15475\u201315482","journal-title":"J Biol Chem"},{"issue":"6236","key":"550_CR10","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/340692a0","volume":"340","author":"CA Landis","year":"1989","unstructured":"Landis CA et al (1989) GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature 340(6236):692\u2013696","journal-title":"Nature"},{"issue":"26","key":"550_CR11","doi-asserted-by":"crossref","first-page":"15467","DOI":"10.1016\/S0021-9258(19)84853-6","volume":"264","author":"SB Masters","year":"1989","unstructured":"Masters SB et al (1989) Mutations in the GTP-binding site of GS alpha alter stimulation of adenylyl cyclase. J Biol Chem 264(26):15467\u201315474","journal-title":"J Biol Chem"},{"issue":"5","key":"550_CR12","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/j.cell.2018.03.018","volume":"173","author":"Q Hu","year":"2018","unstructured":"Hu Q, Shokat KM (2018) Disease-causing mutations in the G protein Galphas subvert the roles of GDP and GTP. Cell 173(5):1254\u20131264","journal-title":"Cell"},{"issue":"6","key":"550_CR13","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1210\/jc.2007-2237","volume":"93","author":"FS Celi","year":"2008","unstructured":"Celi FS et al (2008) The role of type 1 and type 2 5\u2019-deiodinase in the pathophysiology of the 3,5,3\u2019-triiodothyronine toxicosis of McCune-Albright syndrome. J Clin Endocrinol Metab 93(6):2383\u20132389","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"550_CR14","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/j.1399-0004.1986.tb01261.x","volume":"29","author":"R Happle","year":"1986","unstructured":"Happle R (1986) The McCune-Albright syndrome: a lethal gene surviving by mosaicism. Clin Genet 29(4):321\u2013324","journal-title":"Clin Genet"},{"issue":"Suppl 2","key":"550_CR15","doi-asserted-by":"publisher","first-page":"P125","DOI":"10.1359\/jbmr.06s224","volume":"21","author":"M Riminucci","year":"2006","unstructured":"Riminucci M et al (2006) Fibrous dysplasia as a stem cell disease. J Bone Miner Res 21(Suppl 2):P125\u2013P131","journal-title":"J Bone Miner Res"},{"issue":"6","key":"550_CR16","first-page":"1587","volume":"151","author":"M Riminucci","year":"1997","unstructured":"Riminucci M et al (1997) Fibrous dysplasia of bone in the McCune-Albright syndrome: abnormalities in bone formation. Am J Pathol 151(6):1587\u20131600","journal-title":"Am J Pathol"},{"issue":"2","key":"550_CR17","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/(SICI)1096-9896(199901)187:2<249::AID-PATH222>3.0.CO;2-J","volume":"187","author":"M Riminucci","year":"1999","unstructured":"Riminucci M et al (1999) The histopathology of fibrous dysplasia of bone in patients with activating mutations of the Gs alpha gene: site-specific patterns and recurrent histological hallmarks. J Pathol 187(2):249\u2013258","journal-title":"J Pathol"},{"issue":"3","key":"550_CR18","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/S8756-3282(03)00064-4","volume":"33","author":"M Riminucci","year":"2003","unstructured":"Riminucci M et al (2003) Osteoclastogenesis in fibrous dysplasia of bone: in situ and in vitro analysis of IL-6 expression. Bone 33(3):434\u2013442","journal-title":"Bone"},{"issue":"5","key":"550_CR19","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1359\/jbmr.2001.16.5.806","volume":"16","author":"MT Collins","year":"2001","unstructured":"Collins MT et al (2001) Renal phosphate wasting in fibrous dysplasia of bone is part of a generalized renal tubular dysfunction similar to that seen in tumor-induced osteomalacia. J Bone Miner Res 16(5):806\u2013813","journal-title":"J Bone Miner Res"},{"issue":"5","key":"550_CR20","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1172\/JCI18399","volume":"112","author":"M Riminucci","year":"2003","unstructured":"Riminucci M et al (2003) FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J Clin Invest 112(5):683\u2013692","journal-title":"J Clin Invest"},{"issue":"3","key":"550_CR21","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1359\/JBMR.0301264","volume":"19","author":"T Shimada","year":"2004","unstructured":"Shimada T et al (2004) FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 19(3):429\u2013435","journal-title":"J Bone Miner Res"},{"issue":"11","key":"550_CR22","doi-asserted-by":"publisher","first-page":"6500","DOI":"10.1073\/pnas.101545198","volume":"98","author":"T Shimada","year":"2001","unstructured":"Shimada T et al (2001) Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci USA 98(11):6500\u20136505","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"550_CR23","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1002\/jbmr.1546","volume":"27","author":"N Bhattacharyya","year":"2012","unstructured":"Bhattacharyya N et al (2012) Mechanism of FGF23 processing in fibrous dysplasia. J Bone Miner Res 27(5):1132\u20131141","journal-title":"J Bone Miner Res"},{"issue":"11","key":"550_CR24","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1359\/jbmr.080609","volume":"23","author":"SA Kuznetsov","year":"2008","unstructured":"Kuznetsov SA et al (2008) Age-dependent demise of GNAS-mutated skeletal stem cells and \u201cnormalization\u201d of fibrous dysplasia of bone. J Bone Miner Res 23(11):1731\u20131740","journal-title":"J Bone Miner Res"},{"issue":"8","key":"550_CR25","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1172\/JCI2361","volume":"101","author":"P Bianco","year":"1998","unstructured":"Bianco P et al (1998) Reproduction of human fibrous dysplasia of bone in immunocompromised mice by transplanted mosaics of normal and Gsalpha-mutated skeletal progenitor cells. J Clin Invest 101(8):1737\u20131744","journal-title":"J Clin Invest"},{"issue":"4","key":"550_CR26","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1073\/pnas.0707457105","volume":"105","author":"EC Hsiao","year":"2008","unstructured":"Hsiao EC et al (2008) Osteoblast expression of an engineered Gs-coupled receptor dramatically increases bone mass. Proc Natl Acad Sci USA 105(4):1209\u20131214","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"550_CR27","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1002\/jbmr.3","volume":"25","author":"EC Hsiao","year":"2010","unstructured":"Hsiao EC et al (2010) Gs G protein-coupled receptor signaling in osteoblasts elicits age-dependent effects on bone formation. J Bone Miner Res 25(3):584\u2013593","journal-title":"J Bone Miner Res"},{"issue":"11","key":"550_CR28","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1002\/jbmr.2267","volume":"29","author":"I Saggio","year":"2014","unstructured":"Saggio I et al (2014) Constitutive expression of Gsalpha(R201C) in mice produces a heritable, direct replica of human fibrous dysplasia bone pathology and demonstrates its natural history. J Bone Miner Res 29(11):2357\u20132368","journal-title":"J Bone Miner Res"},{"key":"550_CR29","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.bone.2018.02.016","volume":"110","author":"A Karaca","year":"2018","unstructured":"Karaca A et al (2018) Constitutive stimulatory G protein activity in limb mesenchyme impairs bone growth. Bone 110:230\u2013237","journal-title":"Bone"},{"issue":"3","key":"550_CR30","doi-asserted-by":"publisher","first-page":"E418","DOI":"10.1073\/pnas.1714313114","volume":"115","author":"SK Khan","year":"2018","unstructured":"Khan SK et al (2018) Induced Gnas(R201H) expression from the endogenous Gnas locus causes fibrous dysplasia by up-regulating Wnt\/beta-catenin signaling. Proc Natl Acad Sci USA 115(3):E418\u2013e418","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"550_CR31","doi-asserted-by":"publisher","first-page":"E428","DOI":"10.1073\/pnas.1713710115","volume":"115","author":"X Zhao","year":"2018","unstructured":"Zhao X et al (2018) Expression of an active Galphas mutant in skeletal stem cells is sufficient and necessary for fibrous dysplasia initiation and maintenance. Proc Natl Acad Sci U S A 115(3):E428\u2013E437","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"550_CR32","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1359\/jbmr.070511","volume":"22","author":"ES Hart","year":"2007","unstructured":"Hart ES et al (2007) Onset, progression, and plateau of skeletal lesions in fibrous dysplasia and the relationship to functional outcome. J Bone Miner Res 22(9):1468\u20131474","journal-title":"J Bone Miner Res"},{"issue":"6","key":"550_CR33","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1007\/s13244-018-0666-6","volume":"9","author":"YS Kushchayeva","year":"2018","unstructured":"Kushchayeva YS et al (2018) Fibrous dysplasia for radiologists: beyond ground glass bone matrix. Insights Imaging 9(6):1035\u20131056","journal-title":"Insights Imaging"},{"issue":"1","key":"550_CR34","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11832-007-0006-8","volume":"1","author":"AI Leet","year":"2007","unstructured":"Leet AI, Collins MT (2007) Current approach to fibrous dysplasia of bone and McCune-Albright syndrome. J Child Orthop 1(1):3\u201317","journal-title":"J Child Orthop"},{"issue":"4","key":"550_CR35","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1359\/JBMR.0301262","volume":"19","author":"AI Leet","year":"2004","unstructured":"Leet AI et al (2004) Fracture incidence in polyostotic fibrous dysplasia and the McCune-Albright syndrome. J Bone Miner Res 19(4):571\u2013577","journal-title":"J Bone Miner Res"},{"issue":"5","key":"550_CR36","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1007\/s11999-013-3380-1","volume":"472","author":"E Ippolito","year":"2014","unstructured":"Ippolito E et al (2014) Radiographic classification of coronal plane femoral deformities in polyostotic fibrous dysplasia. Clin Orthop Relat Res 472(5):1558\u20131567","journal-title":"Clin Orthop Relat Res"},{"issue":"3","key":"550_CR37","first-page":"531","volume":"86","author":"AI Leet","year":"2004","unstructured":"Leet AI et al (2004) Fibrous dysplasia in the spine: prevalence of lesions and association with scoliosis. 86(3):531\u2013537","journal-title":"Fibrous dysplasia in the spine: prevalence of lesions and association with scoliosis."},{"issue":"2","key":"550_CR38","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s00586-008-0860-1","volume":"18","author":"F Mancini","year":"2009","unstructured":"Mancini F et al (2009) Scoliosis and spine involvement in fibrous dysplasia of bone. Eur Spine J 18(2):196\u2013202","journal-title":"Eur Spine J"},{"issue":"9","key":"550_CR39","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1002\/jbmr.3446","volume":"33","author":"JA Berglund","year":"2018","unstructured":"Berglund JA et al (2018) Scoliosis in Fibrous Dysplasia\/McCune-Albright Syndrome: Factors Associated With Curve Progression and Effects of Bisphosphonates. J Bone Miner Res 33(9):1641\u20131648","journal-title":"J Bone Miner Res"},{"issue":"21","key":"550_CR40","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1056\/NEJMoa020742","volume":"347","author":"JS Lee","year":"2002","unstructured":"Lee JS et al (2002) Normal vision despite narrowing of the optic canal in fibrous dysplasia. N Engl J Med 347(21):1670\u20131676","journal-title":"N Engl J Med"},{"issue":"6","key":"550_CR41","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/odi.12563","volume":"23","author":"AB Burke","year":"2017","unstructured":"Burke AB, Collins MT, Boyce AM (2017) Fibrous dysplasia of bone: craniofacial and dental implications. Oral Dis 23(6):697\u2013708","journal-title":"Oral Dis"},{"issue":"1","key":"550_CR42","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.berh.2007.11.004","volume":"22","author":"RD Chapurlat","year":"2008","unstructured":"Chapurlat RD, Orcel P (2008) Fibrous dysplasia of bone and McCune\u2013Albright syndrome. Best Pract Res Clin Rheumatol. 22(1):55\u201369","journal-title":"Best Pract Res Clin Rheumatol."},{"issue":"7-8","key":"550_CR43","first-page":"293","volume":"51","author":"R Becelli","year":"2002","unstructured":"Becelli R et al (2002) Surgical treatment of fibrous dysplasia of the cranio-maxillo-facial area. Review of the literature and personal experience form 1984 to 1999. Minerva Stomatol 51(7-8):293\u2013300","journal-title":"Minerva Stomatol"},{"issue":"1","key":"550_CR44","doi-asserted-by":"publisher","first-page":"E126","DOI":"10.1210\/jc.2012-2111","volume":"98","author":"AM Boyce","year":"2013","unstructured":"Boyce AM et al (2013) Optic neuropathy in McCune-Albright syndrome: effects of early diagnosis and treatment of growth hormone excess. J Clin Endocrinol Metab 98(1):E126\u2013E134","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"550_CR45","doi-asserted-by":"publisher","first-page":"e25179","DOI":"10.1371\/journal.pone.0025179","volume":"6","author":"M Amit","year":"2011","unstructured":"Amit M et al (2011) Surgery versus watchful waiting in patients with craniofacial fibrous dysplasia\u2013a meta-analysis. PLoS One 6(9):e25179","journal-title":"PLoS One"},{"issue":"2","key":"550_CR46","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1001\/jamaoto.2017.2407","volume":"144","author":"AM Boyce","year":"2018","unstructured":"Boyce AM et al (2018) Association of hearing loss and otologic outcomes with fibrous dysplasia. JAMA Otolaryngol Head Neck Surg 144(2):102\u2013107","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"11","key":"550_CR47","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1002\/jbmr.3531","volume":"33","author":"KS Pan","year":"2018","unstructured":"Pan KS et al (2018) Chiari I malformation and basilar invagination in fibrous dysplasia: prevalence, mechanisms, and clinical implications. J Bone Miner Res. 33(11):1990\u20131998","journal-title":"J Bone Miner Res."},{"issue":"9","key":"550_CR48","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1002\/jbmr.3446","volume":"33","author":"JA Berglund","year":"2018","unstructured":"Berglund JA et al (2018) Scoliosis in fibrous dysplasia\/McCune-Albright syndrome: factors associated with curve progression and effects of bisphosphonates. J Bone Miner Res. 33(9):1641\u20131648","journal-title":"J Bone Miner Res."},{"issue":"1","key":"550_CR49","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00198-007-0425-x","volume":"19","author":"MH Kelly","year":"2008","unstructured":"Kelly MH, Brillante B, Collins MT (2008) Pain in fibrous dysplasia of bone: age-related changes and the anatomical distribution of skeletal lesions. Osteoporos Int 19(1):57\u201363","journal-title":"Osteoporos Int"},{"key":"550_CR50","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1750-1172-3-12","volume":"3","author":"CE Dumitrescu","year":"2008","unstructured":"Dumitrescu CE, Collins MT (2008) McCune-Albright syndrome. Orphanet J Rare Dis 3:12","journal-title":"Orphanet J Rare Dis"},{"key":"550_CR51","first-page":"743","volume":"52","author":"DJ McCune","year":"1936","unstructured":"McCune DJ (1936) Osteitis fibrosa cystica; the case of a nine year old girl who also exhibits precocious puberty, multiple pigmentation of the skin and hyperthyroidism. Am J Dis Child. 52:743\u2013744","journal-title":"Am J Dis Child."},{"issue":"Suppl 1","key":"550_CR52","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1186\/1750-1172-7-S1-S4","volume":"7","author":"MT Collins","year":"2012","unstructured":"Collins MT, Singer FR, Eugster E (2012) McCune-Albright syndrome and the extraskeletal manifestations of fibrous dysplasia. Orphanet J Rare Dis 7(Suppl 1):S4","journal-title":"Orphanet J Rare Dis"},{"issue":"9","key":"550_CR53","doi-asserted-by":"publisher","first-page":"E1782","DOI":"10.1210\/jc.2012-1791","volume":"97","author":"AM Boyce","year":"2012","unstructured":"Boyce AM et al (2012) Characterization and management of testicular pathology in McCune-Albright syndrome. J Clin Endocrinol Metab 97(9):E1782\u2013E1790","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"550_CR54","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1159\/000342641","volume":"78","author":"D Tessaris","year":"2012","unstructured":"Tessaris D et al (2012) Thyroid abnormalities in children and adolescents with McCune-Albright syndrome. Horm Res Paediatr 78(3):151\u2013157","journal-title":"Horm Res Paediatr"},{"issue":"6","key":"550_CR55","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1210\/jc.2013-3826","volume":"99","author":"S Salenave","year":"2014","unstructured":"Salenave S et al (2014) Acromegaly and McCune-Albright syndrome. J Clin Endocrinol Metab 99(6):1955\u20131969","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"550_CR56","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/cen.13722","volume":"89","author":"D Tessaris","year":"2018","unstructured":"Tessaris D et al (2018) Growth hormone-Insulin-like growth factor 1 axis hyperactivity on bone fibrous dysplasia in McCune-Albright Syndrome. Clin Endocrinol (Oxf) 89(1):56\u201364","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"550_CR57","doi-asserted-by":"publisher","first-page":"E126","DOI":"10.1210\/jc.2012-2111","volume":"98","author":"AM Boyce","year":"2012","unstructured":"Boyce AM et al (2012) Optic neuropathy in McCune-Albright syndrome: effects of early diagnosis and treatment of growth hormone excess. J Clin Endocrinol Metab. 98(1):E126\u2013E134","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"550_CR58","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1001\/jamaoto.2017.2407","volume":"144","author":"AM Boyce","year":"2017","unstructured":"Boyce AM et al (2017) Association of hearing loss and otologic outcomes with fibrous dysplasia. JAMA Otolaryngol Head Neck Surg. 144(2):102\u2013107","journal-title":"JAMA Otolaryngol Head Neck Surg."},{"issue":"4","key":"550_CR59","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1210\/jc.2009-2321","volume":"95","author":"RJ Brown","year":"2010","unstructured":"Brown RJ, Kelly MH, Collins MT (2010) Cushing syndrome in the McCune-Albright syndrome. J Clin Endocrinol Metab 95(4):1508\u20131515","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"550_CR60","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1097\/PAS.0b013e31821ec4ce","volume":"35","author":"JA Carney","year":"2011","unstructured":"Carney JA, Young WF, Stratakis CA (2011) Primary bimorphic adrenocortical disease: cause of hypercortisolism in McCune-Albright syndrome. Am J Surg Pathol 35(9):1311\u20131326","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"550_CR61","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1002\/1097-0142(19940301)73:5<1411::AID-CNCR2820730516>3.0.CO;2-T","volume":"73","author":"P Ruggieri","year":"1994","unstructured":"Ruggieri P et al (1994) Malignancies in fibrous dysplasia. Cancer 73(5):1411\u20131424","journal-title":"Cancer"},{"issue":"1","key":"550_CR62","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/jbmr.3286","volume":"33","author":"BC Majoor","year":"2018","unstructured":"Majoor BC et al (2018) Increased risk of breast cancer at a young age in women with fibrous dysplasia. J Bone Miner Res 33(1):84\u201390","journal-title":"J Bone Miner Res"},{"issue":"9","key":"550_CR63","doi-asserted-by":"publisher","first-page":"4413","DOI":"10.1210\/jc.2002-021642","volume":"88","author":"MT Collins","year":"2003","unstructured":"Collins MT et al (2003) Thyroid carcinoma in the McCune-Albright syndrome: contributory role of activating Gs alpha mutations. J Clin Endocrinol Metab 88(9):4413\u20134417","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"550_CR64","doi-asserted-by":"publisher","first-page":"E97","DOI":"10.1210\/jc.2013-1823","volume":"99","author":"S Gaujoux","year":"2014","unstructured":"Gaujoux S et al (2014) Hepatobiliary and Pancreatic neoplasms in patients with McCune-Albright syndrome. J Clin Endocrinol Metab 99(1):E97\u2013E101","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"550_CR65","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1001\/jamasurg.2014.535","volume":"149","author":"A Parvanescu","year":"2014","unstructured":"Parvanescu A et al (2014) Lessons from McCune-Albright syndrome-associated intraductal papillary mucinous neoplasms: : GNAS-activating mutations in pancreatic carcinogenesis. JAMA Surg 149(8):858\u2013862","journal-title":"JAMA Surg"},{"key":"550_CR66","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.bone.2013.11.022","volume":"60","author":"SM Paul","year":"2014","unstructured":"Paul SM et al (2014) Disease severity and functional factors associated with walking performance in polyostotic fibrous dysplasia. Bone 60:41\u201347","journal-title":"Bone"},{"issue":"2","key":"550_CR67","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/jbmr.3602","volume":"34","author":"LF de Castro","year":"2018","unstructured":"de Castro LF et al (2018) Activation of RANK\/RANKL\/OPG pathway is involved in the pathophysiology of fibrous dysplasia and associated with disease burden. J Bone Miner Res. 34(2):290\u2013294","journal-title":"J Bone Miner Res."},{"issue":"1","key":"550_CR68","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.bone.2004.03.004","volume":"35","author":"RD Chapurlat","year":"2004","unstructured":"Chapurlat RD et al (2004) Treatment of fibrous dysplasia of bone with intravenous pamidronate: long-term effectiveness and evaluation of predictors of response to treatment. Bone 35(1):235\u2013242","journal-title":"Bone"},{"issue":"10","key":"550_CR69","doi-asserted-by":"publisher","first-page":"4569","DOI":"10.1210\/jc.2003-030050","volume":"88","author":"H Plotkin","year":"2003","unstructured":"Plotkin H et al (2003) Effect of pamidronate treatment in children with polyostotic fibrous dysplasia of bone. J Clin Endocrinol Metab 88(10):4569\u20134575","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"550_CR70","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1002\/jbmr.2999","volume":"32","author":"BC Majoor","year":"2017","unstructured":"Majoor BC et al (2017) Outcome of long-term bisphosphonate therapy in McCune-Albright syndrome and polyostotic fibrous dysplasia. J Bone Miner Res 32(2):264\u2013276","journal-title":"J Bone Miner Res"},{"issue":"4","key":"550_CR71","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/S8756-3282(03)00221-7","volume":"33","author":"MS Parisi","year":"2003","unstructured":"Parisi MS, Oliveri B, Mautalen CA (2003) Effect of intravenous pamidronate on bone markers and local bone mineral density in fibrous dysplasia. Bone 33(4):582\u2013588","journal-title":"Bone"},{"issue":"Suppl 3","key":"550_CR72","first-page":"929","volume":"15","author":"P Matarazzo","year":"2002","unstructured":"Matarazzo P et al (2002) Pamidronate treatment in bone fibrous dysplasia in children and adolescents with McCune-Albright syndrome. J Pediatr Endocrinol Metab 15(Suppl 3):929\u2013937","journal-title":"J Pediatr Endocrinol Metab"},{"key":"550_CR73","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.3649","author":"P Florenzano","year":"2019","unstructured":"Florenzano P et al (2019) Age-related changes and effects of bisphosphonates on bone turnover and disease progression in fibrous dysplasia of bone. J Bone Miner Res. https:\/\/doi.org\/10.1002\/jbmr.3649","journal-title":"J Bone Miner Res"},{"issue":"11","key":"550_CR74","doi-asserted-by":"publisher","first-page":"4133","DOI":"10.1210\/jc.2014-1371","volume":"99","author":"AM Boyce","year":"2014","unstructured":"Boyce AM et al (2014) A randomized, double blind, placebo-controlled trial of alendronate treatment for fibrous dysplasia of bone. J Clin Endocrinol Metab 99(11):4133\u20134140","journal-title":"J Clin Endocrinol Metab"},{"key":"550_CR75","unstructured":"Boyce, A.M., et al., Fibrous Dysplasia\/McCune-Albright Syndrome, in GeneReviews((R)), M.P. Adam, et al., Editors. 1993, University of Washington, Seattle University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.: Seattle (WA)."},{"issue":"10","key":"550_CR76","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1016\/j.joms.2016.04.001","volume":"74","author":"T Metwally","year":"2016","unstructured":"Metwally T et al (2016) Fibrous dysplasia and medication-related osteonecrosis of the jaw. J Oral Maxillofac Surg 74(10):1983\u20131999","journal-title":"J Oral Maxillofac Surg"},{"issue":"7","key":"550_CR77","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1002\/jbmr.1603","volume":"27","author":"AM Boyce","year":"2012","unstructured":"Boyce AM et al (2012) Denosumab treatment for fibrous dysplasia. J Bone Miner Res 27(7):1462\u20131470","journal-title":"J Bone Miner Res"},{"issue":"2","key":"550_CR78","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s00198-013-2585-1","volume":"25","author":"K Ganda","year":"2014","unstructured":"Ganda K, Seibel MJ (2014) Rapid biochemical response to denosumab in fibrous dysplasia of bone: report of two cases. Osteoporos Int 25(2):777\u2013782","journal-title":"Osteoporos Int"},{"issue":"6","key":"550_CR79","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.jbspin.2014.04.013","volume":"81","author":"J Benhamou","year":"2014","unstructured":"Benhamou J, Gensburger D, Chapurlat R (2014) Transient improvement of severe pain from fibrous dysplasia of bone with denosumab treatment. Joint Bone Spine 81(6):549\u2013550","journal-title":"Joint Bone Spine"},{"issue":"Suppl 1","key":"550_CR80","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1186\/1750-1172-7-S1-S1","volume":"7","author":"RP Stanton","year":"2012","unstructured":"Stanton RP et al (2012) The surgical management of fibrous dysplasia of bone. Orphanet J Rare Dis 7(Suppl 1):S1","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"550_CR81","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1007\/s11999-016-4806-3","volume":"475","author":"BC Majoor","year":"2017","unstructured":"Majoor BC et al (2017) What is the role of allogeneic cortical strut grafts in the treatment of fibrous dysplasia of the proximal femur? Clin Orthop Relat Res 475(3):786\u2013795","journal-title":"Clin Orthop Relat Res"},{"issue":"3","key":"550_CR82","doi-asserted-by":"publisher","first-page":"211","DOI":"10.2106\/JBJS.O.00547","volume":"98","author":"AI Leet","year":"2016","unstructured":"Leet AI et al (2016) Bone-grafting in polyostotic fibrous dysplasia. J Bone Joint Surg Am 98(3):211\u2013219","journal-title":"J Bone Joint Surg Am"},{"issue":"6","key":"550_CR83","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1097\/PRS.0000000000002151","volume":"137","author":"AM Boyce","year":"2016","unstructured":"Boyce AM et al (2016) Surgical management of polyostotic craniofacial fibrous dysplasia: long-term outcomes and predictors for postoperative regrowth. Plast Reconstr Surg 137(6):1833\u20131839","journal-title":"Plast Reconstr Surg"},{"issue":"5","key":"550_CR84","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1530\/EJE-16-0526","volume":"175","author":"A Estrada","year":"2016","unstructured":"Estrada A et al (2016) Long-term outcomes of letrozole treatment for precocious puberty in girls with McCune-Albright syndrome. Eur J Endocrinol 175(5):477\u2013483","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"550_CR85","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/S0022-3476(03)00128-8","volume":"143","author":"EA Eugster","year":"2003","unstructured":"Eugster EA et al (2003) Tamoxifen treatment for precocious puberty in McCune\u2013Albright syndrome: a multicenter trial. J Pediatr 143(1):60\u201366","journal-title":"J Pediatr"},{"issue":"6","key":"550_CR86","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1210\/jc.2013-3826","volume":"99","author":"S Salenave","year":"2014","unstructured":"Salenave S et al (2014) Acromegaly and McCune\u2013Albright syndrome. J Clin Endocrinol Metab 99(6):1955\u20131969","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"550_CR87","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1210\/jc.2012-1274","volume":"97","author":"AO Vortmeyer","year":"2012","unstructured":"Vortmeyer AO et al (2012) Somatic GNAS mutation causes widespread and diffuse pituitary disease in acromegalic patients with McCune\u2013Albright syndrome. J Clin Endocrinol Metab 97(7):2404\u20132413","journal-title":"J Clin Endocrinol Metab"},{"issue":"5\u20136","key":"550_CR88","first-page":"283","volume":"24","author":"F Liu","year":"2011","unstructured":"Liu F et al (2011) A case of McCune\u2013Albright syndrome associated with pituitary GH adenoma: therapeutic process and autopsy. J Pediatr Endocrinol Metab 24(5\u20136):283\u2013287","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"2","key":"550_CR89","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1055\/s-2003-40597","volume":"13","author":"MR Hansen","year":"2003","unstructured":"Hansen MR, Moffat JC (2003) Osteosarcoma of the skull base after radiation therapy in a PATIENT with McCune\u2013Albright syndrome: case report. Skull Base 13(2):79\u201383","journal-title":"Skull Base"},{"issue":"7","key":"550_CR90","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1002\/jbmr.340","volume":"26","author":"TO Carpenter","year":"2011","unstructured":"Carpenter TO et al (2011) A clinician\u2019s guide to X-linked hypophosphatemia. J Bone Miner Res 26(7):1381\u20131388","journal-title":"J Bone Miner Res"},{"issue":"Suppl 1","key":"550_CR91","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1186\/1750-1172-7-S1-S3","volume":"7","author":"RD Chapurlat","year":"2012","unstructured":"Chapurlat RD et al (2012) Pathophysiology and medical treatment of pain in fibrous dysplasia of bone. Orphanet J Rare Dis 7(Suppl 1):S3","journal-title":"Orphanet J Rare Dis"},{"issue":"9","key":"550_CR92","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1093\/rheumatology\/kev221","volume":"54","author":"H de Boysson","year":"2015","unstructured":"de Boysson H et al (2015) Tocilizumab in the treatment of a polyostotic variant of fibrous dysplasia of bone. Rheumatology 54(9):1747\u20131749","journal-title":"Rheumatology"},{"issue":"3","key":"550_CR93","doi-asserted-by":"publisher","first-page":"e90766","DOI":"10.1371\/journal.pone.0090766","volume":"9","author":"N Bhattacharyya","year":"2014","unstructured":"Bhattacharyya N et al (2014) A high throughput screening assay system for the identification of small molecule inhibitors of gsp. PLoS ONE 9(3):e90766","journal-title":"PLoS ONE"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-019-00550-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00223-019-00550-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-019-00550-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T21:31:13Z","timestamp":1663363873000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-019-00550-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,29]]},"references-count":93,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["550"],"URL":"https:\/\/doi.org\/10.1007\/s00223-019-00550-z","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,29]]},"assertion":[{"value":"8 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}